Author:
Yu Yani,Yu Jia,Cui Xiaorong,Sun Xin,Yu Xiaohui
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Reference35 articles.
1. Dai J, Pan Y, Chen Y, Yao S. A panel of seven immune-related genes can serve as a good predictive biomarker for cervical squamous cell carcinoma. Front Genet. 2022;13:1024508.
2. Chen P, Jiao L, Ren F, Wang DB. Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma. BMC Cancer. 2020;20:423.
3. Xie N, et al. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma. J Oral Pathol Med. 2015;44:266–72.
4. Gliniewicz A, Zielinska A, Kwiatkowska K, Dudek-Godeau D, Bielska-Lasota M. Survival in women diagnosed with breast and cervical cancer in Poland–compared to European countries, based on CONCORD - 3 Programme. Przegl Epidemiol. 2018;72:499–508.
5. Gomez-Vargas V, et al. Screening history and survival among women with cervical cancer in Puerto Rico. J Low Genit Tract Dis. 2023;27:19–23.